LOS ANGELES, Aug. 8, 2019 /PRNewswire/ -- Adnant, an accounting and consulting firm, is hosting a networking event at Outside Lands that will bring together top cannabis brands, executives and investors. Outside Lands takes place in San Francisco's Golden Gate Park from August 9-11, 2019. The festival is

NEW YORK, Aug. 8, 2019 /PRNewswire/ -- Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of Corindus Vascular Robotics, Inc. (NYSE: CVRS) on behalf of Corindus shareholders concerning the proposed merger with a subsidiary of Siemens Healthineers AG.

CHICAGO, Aug. 8, 2019 /PRNewswire/ -- Gun violence in the United States is a public health crisis and should be addressed much as the government studies motor vehicle deaths, according to the president of the American Psychological Association.

In the news release, Achieve Reports Financial Results for Second Quarter 2019 and Provides Cytisinicline Clinical Development Update, issued 08-Aug-2019 by Achieve Life Sciences, Inc. over PR Newswire, we are advised by the company that the column headers in the Consolidated Statements of Loss table have been updated. The complete, corrected release follows:Achieve Reports Financial Results for

MARIETTA, Ga., Aug. 8, 2019 /PRNewswire/ -- MiMedx Group, Inc. (OTC PINK: MDXG) ("MiMedx" or the "Company"), an industry leader in advanced wound care and an emerging therapeutic biologics company, today announced an agreement with the plaintiff (the "Plaintiff") in the matter City of Hialeah Employees' Retirement System v. MiMedx Group, Inc. As has been previousl

FLINT, Mich., Aug. 8, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), is pleased to announce an exclusive agreement between Diplomat and Allergy Partners, P.A., to manage in-office and in-home delivery and administration of infusion drugs and biologics. The agreement will cover treatments for primary immunodeficiency, alpha-1 antitrypsin deficiency,

WINNIPEG, Aug. 8, 2019 /PRNewswire/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a pharmaceutical company, today reported its results from operations for the quarter ended June 30, 2019.  Quarter Ended June 30, 2019 Highlights:

SAN ANTONIO, Aug. 8, 2019 /PRNewswire/ -- When Americans return to work and school after summer vacation, the fall allergy season will begin to impact many of the nearly 50 million allergy sufferers across the country1. According to the Asthma and Allergy Foundation of America, Americans lost more than 6 million work and school days in 2018, costing about

GERMANTOWN, Md., Aug. 8, 2019 /PRNewswire/ -- Intrexon Corporation (NASDAQ: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of

NEW HAVEN, Conn., Aug. 8, 2019 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN, the "Company"), a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological and neuropsychiatric diseases, today reported financial results for the quarter ended June 30, 2019, and prov